TrialMedical oncology (Northwood, London, England)2023

A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.

Yan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.